Cribstone Capital Management, LLC Gilead Sciences, Inc. Transaction History
Cribstone Capital Management, LLC
- $169 Million
- Q4 2022
A detailed history of Cribstone Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cribstone Capital Management, LLC holds 2,810 shares of GILD stock, worth $256,693. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,810
Previous 2,810
-0.0%
Holding current value
$256,693
Previous $173,000
39.31%
% of portfolio
0.14%
Previous 0.11%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
1,927Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.5 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.99 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.65 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.5 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $114B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...